WHO Backs GLP-1 Treatments To Tackle Obesity Epidemic
A new generation of appetite-suppressing drugs called GLP-1 agonists — which includes blockbuster brands Ozempic and Mounjaro — has become massively popular in recent years.
Tag: Ozempic
Why Kenya Is Warning Against the Misuse of Ozempic
Globally, Ozempic has been branded on social media as a “miracle weight-loss jab.” Influencers and celebrities are openly endorsing it, driving demand even among people without diabetes
